のれん（IFRS）、特許実施権、外部収益 - 水処理薬品事業
- 【期間】
| 年度 | のれん（IFRS） | 特許実施権 | 外部収益 - 水処理薬品事業 |
|---|
| 2015/03 | - | | - | | - | |
| 2015/06 | - | | - | | - | |
| 2015/09 | - | | - | | - | |
| 2015/12 | - | | - | | - | |
| 2016/03 | - | | - | | - | |
| 2016/06 | - | | - | | - | |
| 2016/09 | - | | - | | - | |
| 2016/12 | - | | - | | - | |
| 2017/03 | - | | - | | - | |
| 2017/06 | - | | - | | - | |
| 2017/09 | - | | - | | - | |
| 2017/12 | - | | - | | - | |
| 2018/03 | - | | - | | - | |
| 2018/06 | - | | - | | 254億 | |
| 2018/09 | - | | - | | 519億 | +104.1% |
| 2018/12 | - | | - | | 774億 | +49.2% |
| 2019/03 | 438億 | | - | | 1021億 | +31.9% |
| 2019/06 | 450億 | +2.7% | - | | 280億 | -72.6% |
| 2019/09 | 446億 | -0.8% | - | | 585億 | +108.7% |
| 2019/12 | 457億 | +2.5% | - | | 869億 | +48.5% |
| 2020/03 | 470億 | +2.9% | - | | 1136億 | +30.8% |
| 2020/06 | 564億 | +20% | - | | 245億 | -78.4% |
| 2020/09 | 560億 | -0.8% | - | | 515億 | +110.1% |
| 2020/12 | 556億 | -0.7% | - | | 775億 | +50.5% |
| 2021/03 | 556億 | -0% | - | | 1032億 | +33.2% |
| 2021/06 | 583億 | +4.9% | - | | 279億 | -73% |
| 2021/09 | 588億 | +0.9% | - | | 581億 | +108.2% |
| 2021/12 | 600億 | +2% | - | | 879億 | +51.2% |
| 2022/03 | 630億 | +5% | - | | 1177億 | +33.9% |
| 2022/06 | 689億 | +9.4% | - | | 325億 | -72.4% |
| 2022/09 | 715億 | +3.8% | - | | 684億 | +110.7% |
| 2022/12 | 673億 | -5.9% | - | | 1029億 | +50.5% |
| 2023/03 | 604億 | -10.3% | - | | 1361億 | +32.3% |
| 2023/06 | 655億 | +8.5% | - | | - | |
| 2023/09 | 694億 | +5.9% | - | | - | |
| 2023/12 | 669億 | -3.6% | - | | - | |
| 2024/03 | 710億 | +6.1% | - | | - | |
| 2024/06 | 752億 | +5.9% | - | | - | |
